A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease | MicrobiomeTrials← Back to trialsNCT07814352
A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-09-04Est. Completion: 2029-09
Enrollment target: 40 participants Locations- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack, New York, United States
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
Other microbiome trials you might be interested in
Advanced Solid Tumor, AdultERBB2 Altered Breast CancerERBB2 Gene AmplificationHER2 OverexpressionNon-Small Cell Lung CancerHER2
This is an open-label, phase 1/1b study evaluating the safety, tolerability, pharmacokinetic (what the body does to the …
Scottsdale, United StatesEst. completion May 2028
Breast Cancer, Quality of LifeBreast Cancer, MetastaticBreast Cancer, Metastatic Breast Cancer
Leptomeningeal Metastasis of Breast Cancer
Brain Metastases From Breast Cancer
Central nervous system (CNS) metastases including breast cancer brain metastases (BCBMs) and leptomeningeal disease (LMD…
San Francisco, United StatesEst. completion Dec 31, 2030